Literature DB >> 12598308

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Karl Sotlar1, Luis Escribano, Olfert Landt, Stefanie Möhrle, Sonia Herrero, Antonio Torrelo, Ulrich Lass, Hans-Peter Horny, Burkhard Bültmann.   

Abstract

The prognostic significance of somatic activating codon 816 c-kit mutations in pediatric urticaria pigmentosa has not yet been established in detail. Detection of such mutations in archival paraffin-embedded biopsies is usually hampered by an abundance of surrounding normal cells. Here we describe a method for the selective amplification and specific detection of c-kit mutation Asp816-->Val in complete tissue sections cut from up to 24-year-old paraffin blocks. Peptide nucleic acid-mediated polymerase chain reaction clamping of the wild-type allele was combined with on-line mutation detection using oligonucleotide hybridization probes. In DNA extracted from HMC-1 cells heterozygously carrying the c-kit mutation Asp816-->Val, the one-tube assay allowed specific detection of this mutation in a more than 1000-fold excess of normal background DNA within 1 hour and without the need for additional analytical steps. In a series of 38 cases with pediatric urticaria pigmentosa we detected c-kit codons 815 and 816 mutations in 16 cases. Mutation detection did not correlate with clinical outcome after a mean follow-up of 11.2 years. In conclusion, the procedure described may represent an ideal screening tool for all kinds of clinical applications, using point mutations as markers of, for example, early events in carcinogenesis, circulating metastatic tumor cells, and minimal residual disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598308      PMCID: PMC1868096          DOI: 10.1016/S0002-9440(10)63870-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis.

Authors:  K S Elenitoba-Johnson; S D Bohling; C T Wittwer; T C King
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

2.  Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.

Authors:  A V Lichtenstein; O I Serdjuk; T I Sukhova; H S Melkonyan; S R Umansky
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Detection of tumor mutations in the presence of excess amounts of normal DNA.

Authors:  Xiyuan Sun; K Hung; L Wu; D Sidransky; Baochuan Guo
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

Review 4.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 5.  Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.

Authors:  L Escribano; B Díaz-Agustín; C Bellas; R Navalón; R Nuñez; W R Sperr; G H Schernthaner; P Valent; A Orfao
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

6.  Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes.

Authors:  E Barragán; P Bolufer; I Moreno; G Martín; J Nomdedeu; S Brunet; P Fernández; C Rivas; M A Sanz
Journal:  Leuk Lymphoma       Date:  2001-08

7.  Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.

Authors:  G Porto; H Alves; P Rodrigues; J M Cabeda; C Portal; A Ruivo; B Justiça; R Wolff; M De Sousa
Journal:  Immunogenetics       Date:  1998-04       Impact factor: 2.846

8.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

9.  Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.

Authors:  Karl Sotlar; Claudius Fridrich; Adelheid Mall; Ralf Jaussi; Burkhard Bültmann; Peter Valent; Hans-Peter Horny
Journal:  Leuk Res       Date:  2002-11       Impact factor: 3.156

Review 10.  PCR clamping.

Authors:  H Orum
Journal:  Curr Issues Mol Biol       Date:  2000-01       Impact factor: 2.081

View more
  53 in total

1.  Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.

Authors:  T Gülen; B Sander; G Nilsson; J Palmblad; K Sotlar; H-P Horny; H Hägglund
Journal:  Med Oncol       Date:  2012-06-03       Impact factor: 3.064

2.  "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

Authors:  K Sotlar; W Saeger; F Stellmacher; J Stahmer; S Jäckle; P Valent; H-P Horny
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.

Authors:  Robert Fritsche-Polanz; Marika Fritz; Andrea Huber; Karl Sotlar; Wolfgang R Sperr; Christine Mannhalter; Manuela Födinger; Peter Valent
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

4.  Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.

Authors:  Oscar Fuster; Eva Barragán; Pascual Bolufer; José Cervera; Maria José Larráyoz; Antonio Jiménez-Velasco; Joaquín Martínez-López; Ana Valencia; Federico Moscardó; Miguel Angel Sanz
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

5.  Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.

Authors:  Thomas Kristensen; Hanne Vestergaard; Michael Boe Møller
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

6.  Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.

Authors:  Maria Jara-Acevedo; Cristina Teodosio; Laura Sanchez-Muñoz; Ivan Álvarez-Twose; Andrea Mayado; Carolina Caldas; Almudena Matito; José M Morgado; Javier I Muñoz-González; Luis Escribano; Andrés C Garcia-Montero; Alberto Orfao
Journal:  Mod Pathol       Date:  2015-06-12       Impact factor: 7.842

Review 7.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

8.  C-kit gene mutation in human gastrointestinal stromal tumors.

Authors:  Ying-Yong Hou; Yun-Shan Tan; Meng-Hong Sun; Yong-Kun Wei; Jian-Fang Xu; Shao-Hua Lu; Su-Jie A-Ke-Su; Yan-Nan Zhou; Feng Gao; Ai-Hua Zheng; Tai-Ming Zhang; Wen-Zhong Hou; Jian Wang; Xiang Du; Xiong-Zeng Zhu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

9.  Mastocytosis: a disease of the hematopoietic stem cell.

Authors:  Hans-Peter Horny; Karl Sotlar; Peter Valent; Karin Hartmann
Journal:  Dtsch Arztebl Int       Date:  2008-10-03       Impact factor: 5.594

10.  Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.

Authors:  Karl Sotlar; Anja Bache; Florian Stellmacher; Burkhard Bültmann; Peter Valent; Hans-Peter Horny
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.